Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
A study of more than 80,000 women found that low to moderate alcohol consumption was associated with a 17% to 21% reduction in risk of stroke.…
Read More »Weekly Exenatide Superior to Glargine over Long Term
In the longest controlled clinical trial of exenatide compared with daily insulin glargine, investigators found better glycemic control and sustained weight loss for up to 84 weeks with once weekly exenatide (EQW).…
Read More »High Blood Glucose Increases CKD Chances in Elderly
Elderly people with the metabolic syndrome defined as having multiple risk factors associated with developing diabetes and heart disease, had an increased risk of CKD….
Read More »Joslin’s Diabetes Deskbook, A Guide for Primary Care Providers, Updated 2nd Ed., Excerpt 1: What Are the Five Steps to Patient Adherence?
By Richard S. Beaser, M.D. and Richard Jackson, MD The Approach to Diagnosis and Treatment: Collaboration is Key to Adherence The gap in meeting clinical targets is in large part due to the gap that presently exists between actual and optimal treatment goals and strategies for patients and physicians. Even when …
Read More »Hypo and Hyperglycemia, Part 2 of 4
This week, we have Part 2 of our Homerun Slides on Hypo and Hyperglycemia focusing on how different types of insulin can result in various effects which if not managed correctly, may result in hypoglycemia…
Read More »GLP-1 Analogs and DeFronzo’s Octet
For over two decades, GLP-1 has been heavily investigated as the most promising therapy target in type 2 diabetes patients….
Read More »Abbott’s New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance
Abbott’s New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance The new InsuLinx includes a touch-screen interface, automated logbook, USB Connectivity for Plug-and-Play Reports, and several personalization features designed to improve the diabetes management experience for patients that includes a mealtime (bolus) insulin calculator for calculating suggested insulin doses. …
Read More »Stop Using Sulfonylureas?
The ACP has issued a clinical practice guideline regarding use of oral agents in type 2 diabetes entitled, “Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians.”… This is important because despite new therapies, there hasn’t been a guideline from either …
Read More »Duration of Diabetes Raises Stroke Risk
The risk of ischemic stroke increased by 3% for each additional year a patient had diabetes.…
Read More »FDA Adds Diabetes Warning to Statin Label
The FDA said last week that all statins must carry warnings about increased risks of elevated blood sugar and possible transient memory and cognition problems, but at the same time the agency removed a standing recommendation for routine liver function tests for patients taking the cholesterol-lowering drugs.…
Read More »